Shortlist Announced for Astellas European Foundation Transplantation Grant

Chertsey, England (ots/PRNewswire) -

$150,000 Grant will be awarded on Saturday 24th January

The Astellas European Foundation has announced the shortlist for
the Transplantation Grant. The Grant programme supports basic medical
and related scientific programmes which contribute to advancements in
transplantation. The five finalists are from Denmark, Germany, The
Netherlands, Romania, and Switzerland. The winner will be announced
at the Advancing Transplantation Meeting, being held at the
Karonlinska Institutet, Stockholm, Sweden, between 24th and 26th
January, 2015.

The shortlisted projects:

Professor Allan Rasmussen, Rigshospitalet, Copenhagen, Denmark,
'Donor Specific Antibodies in Liver Transplantation: a prospective
blinded multicenter prognostic study'

Dr. Robert Öllinger, Charité Virchow Klinikum, Berlin, Germany,
'Bariatric procedures in morbidly obese patients with renal
insufficiency to enable kidney transplantation'

Dr Gertrude Nieuwenhuijs-Moeke, University Medical Centre
Groningen, The Netherlands, 'Volatile Anesthetic Protection of Renal
Transplants-2'

Professor Ilhan Inci, University Hospital Zurich, Switzerland,
'Randomized placebo controlled trial of N-acetylcysteine in a pig
lung transplant survival model'

Professor Irinel Popescu, Fundeni Clinical Institute, Bucharest,
Romania, 'Association of de novo donor specific anti-HLA antibodies
and liver allograft outcome according to ABCB1 and CYP3A5 genotypes'

The Astellas European Foundation is a registered charity with the
long-term goal of providing support for programmes and activities
that advance our understanding of medicine and health. The winner of
the Grant is selected by a Judging Faculty that includes independent
European thought leaders.

Dr Ayad Abdulahad, Astellas European Foundation Trustee and Senior
Vice President of Medical Affairs and Health Economics for Astellas
Pharma EMEA commented: "We received a record 98 applications from
research institutions and hospitals across Europe. The Foundation
looks forward to announcing the winner later this month and is
pleased to share the shortlist entrants who have succeeded in
reaching the final stage. We would like to thank all the institutions
that have expressed their interest with applications."

The Foundation now offers annual Grants of $150,000 for
Uro-Oncology, Functional Urology and Uro-Gynaecology, and
Transplantation. For information regarding the Grant process please
contact the Astellas European Foundation by email at aef@astellas.com
or call +44-203-379-8039.

Notes to Editors

About The Astellas European Foundation

The Astellas European Foundation is a registered charity, formed
in 2005, with the long-term goal of providing support for programmes
and activities that contribute to the advancement of an increasingly
healthy society. In line with this aim, the Foundation has made
substantial donations to global charities. The Astellas European
Foundation also supports Astellas employees in their private
fundraising efforts for charitable causes. The Astellas European
Foundation is registered with the Charity Commission for England and
Wales, number 1036344.

The Astellas European Foundation was established by funding from
Astellas Pharma Inc, but operates independently of it.

ots Originaltext: Astellas European Foundation
Im Internet recherchierbar: http://www.presseportal.de

Contact:
For further information, please contact:
Joe Barker, Astellas European Foundation Manager
Tel: +44-(0)-203-379-8039
Email: joe.barker@astellas.com